[go: up one dir, main page]

ZA200203008B - Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis. - Google Patents

Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.

Info

Publication number
ZA200203008B
ZA200203008B ZA200203008A ZA200203008A ZA200203008B ZA 200203008 B ZA200203008 B ZA 200203008B ZA 200203008 A ZA200203008 A ZA 200203008A ZA 200203008 A ZA200203008 A ZA 200203008A ZA 200203008 B ZA200203008 B ZA 200203008B
Authority
ZA
South Africa
Prior art keywords
giardiasis
prophylaxis
treatment
lactic acid
acid bacteria
Prior art date
Application number
ZA200203008A
Other languages
English (en)
Inventor
Eduardo Schiffrin
Pablo Perez
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of ZA200203008B publication Critical patent/ZA200203008B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
ZA200203008A 1999-10-26 2002-04-16 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis. ZA200203008B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99121356 1999-10-26

Publications (1)

Publication Number Publication Date
ZA200203008B true ZA200203008B (en) 2003-09-23

Family

ID=8239282

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203008A ZA200203008B (en) 1999-10-26 2002-04-16 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.

Country Status (19)

Country Link
US (2) US6905679B1 (xx)
EP (1) EP1227827B1 (xx)
CN (1) CN1281220C (xx)
AP (1) AP1563A (xx)
AR (1) AR026248A1 (xx)
AT (1) ATE290393T1 (xx)
AU (1) AU1025001A (xx)
BR (1) BR0015102B1 (xx)
CA (1) CA2388952C (xx)
CO (1) CO5280049A1 (xx)
DE (1) DE60018591T2 (xx)
DK (1) DK1227827T3 (xx)
ES (1) ES2239622T3 (xx)
MX (1) MXPA02004115A (xx)
OA (1) OA12074A (xx)
PE (1) PE20010676A1 (xx)
PT (1) PT1227827E (xx)
WO (1) WO2001030365A1 (xx)
ZA (1) ZA200203008B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1227827B1 (en) 1999-10-26 2005-03-09 Societe Des Produits Nestle S.A. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
BRPI0808391A2 (pt) 2007-02-01 2014-07-08 Lams Company Método para diminuir a inflamação e o estresse em um mamífero, mediante o uso de antimetabólitos de glicose, abacate ou extratos de abacate.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
JP2012526752A (ja) 2009-05-11 2012-11-01 ネステク ソシエテ アノニム ビフィドバクテリウム・ロンガムncc2705(cncmi−2618)及び免疫障害
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP3011966A1 (en) 2014-08-08 2016-04-27 Institut National De La Recherche Agronomique Compositions for the inhibition of Giardia Lamblia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172245T1 (de) * 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
US5902578A (en) 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
ES2226228T5 (es) * 1999-04-30 2009-01-16 Societe Des Produits Nestle S.A. Crecimiento mejorado de las bacterias del acido lactico en la leche.
EP1227827B1 (en) 1999-10-26 2005-03-09 Societe Des Produits Nestle S.A. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis

Also Published As

Publication number Publication date
AU1025001A (en) 2001-05-08
CN1281220C (zh) 2006-10-25
DK1227827T3 (da) 2005-07-11
MXPA02004115A (es) 2002-10-17
EP1227827A1 (en) 2002-08-07
OA12074A (en) 2006-05-04
CA2388952A1 (en) 2001-05-03
CO5280049A1 (es) 2003-05-30
DE60018591T2 (de) 2006-04-13
EP1227827B1 (en) 2005-03-09
ATE290393T1 (de) 2005-03-15
CA2388952C (en) 2008-06-10
PE20010676A1 (es) 2001-07-11
BR0015102A (pt) 2002-07-16
US20050186191A1 (en) 2005-08-25
AP2002002483A0 (en) 2002-06-30
BR0015102B1 (pt) 2014-03-18
CN1382056A (zh) 2002-11-27
AR026248A1 (es) 2003-02-05
US6905679B1 (en) 2005-06-14
WO2001030365A1 (en) 2001-05-03
US7229616B2 (en) 2007-06-12
AP1563A (en) 2006-02-02
DE60018591D1 (de) 2005-04-14
PT1227827E (pt) 2005-07-29
ES2239622T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
MX236443B (es) Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias.
MXPA03007881A (es) Bacterias productoras de acido lactico para tratar y prevenir la alergia.
ZA200107294B (en) Lactic acid bacteria strains capable of preventing diarrhoea.
MXPA02003179A (es) Uso de retigabina para el tratamiento de dolor neuropatico.
PT1322318E (pt) Utilização de bactérias ácido lácticas probióticas para prevenção de reacções inflamatórias ou alérgicas ou imunossupressão induzidas por radiações ultravioleta na pele
ZA200108912B (en) Attenuated microorganisms for the treatment of infection.
MXPA02005735A (es) Tratamieno de enzimas para infeccion.
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
ZA200007642B (en) Treatment of airborne microorganisms.
ZA200108446B (en) Novel method of treatment.
HUP0300025A3 (en) Somnogenic activity of non-pathogenic lactic acid bacteria
ZA200203008B (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
MXPA02009342A (es) Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
HUP0202345A3 (en) Method of purifying water, suitable bacteria for the method and use thereof
NZ513686A (en) Treatment of trauma
ZA200004363B (en) Treatment or prevention of coccidiosis.
AU1393801A (en) Method for the treatment and/or prophylaxis of diseases caused by il-12
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
AUPQ051099A0 (en) Novel products and processes in treatment and/or prophylaxis
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
AU2003304316A8 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2003204710A1 (en) Attenuated microorganisms for the treatment of infection
AUPQ200399A0 (en) Novel products and processes in treatment and/or prophylaxis
HK1054557A (en) Compounds and methods for the treatment and prevention of bacterial infection
DK1178730T3 (da) Anvendelse af mælkesyrebakterier til fremstilling af fermenterede mælkeprodukter til behandling af svækkede immunitetsniveauer